Design and Rationale of the Sevoflurane for Sedation in Acute Respiratory Distress Syndrome (SESAR) Randomized Controlled Trial.
Domains
ImmunologyOrigin | Publication funded by an institution |
---|
Origin | Publication funded by an institution |
---|
Matthieu Jabaudon : Connect in order to contact the contributor
https://hal.science/hal-03967648
Submitted on : Friday, February 23, 2024-3:55:06 PM
Last modification on : Friday, February 23, 2024-4:17:46 PM